Publicaciones en colaboración con investigadores/as de Yale School of Medicine (6)

2016

  1. Empagliflozin and progression of kidney disease in type 2 diabetes

    New England Journal of Medicine, Vol. 375, Núm. 4, pp. 323-334

2015

  1. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes

    New England Journal of Medicine, Vol. 373, Núm. 22, pp. 2117-2128

1981

  1. Low plasma renin activity in normotensive patients with diabetes mellitus: Relationship to neuropathy

    Hypertension, Vol. 3, Núm. 1, pp. 87-92

1977

  1. Age and the Renin-Aldosterone System

    Archives of Internal Medicine, Vol. 137, Núm. 10, pp. 1414-1417

1975

  1. Effects of an angiotensin inhibitor on adrenocortical response to angiotensin II, ACTH, and K

    American Journal of Physiology, Vol. 229, Núm. 6, pp. 1713-1717

  2. Glucagon stimulation of plasma renin activity in humans

    Journal of Clinical Endocrinology and Metabolism, Vol. 41, Núm. 1, pp. 183-185